{
    "2019-12-27": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Dividend-Paying Large Cap Pharma Stocks to Consider for 2020",
                "features": {
                    "keywords": [
                        "dividend-paying",
                        "large cap",
                        "pharma stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Bet on These 5 Low Leverage Stocks to Invest Judiciously",
                "features": {
                    "keywords": [
                        "low leverage",
                        "stocks",
                        "invest judiciously"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Johnson and Johnson Isn't Quite as Cheap as Morgan Stanley Thinks It Is",
                "features": {
                    "keywords": [
                        "Johnson and Johnson",
                        "cheap",
                        "Morgan Stanley"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Johnson & Johnson's Tremfya Plaque-Psoriasis Treatment Is Cleared by China for Import",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Tremfya",
                        "plaque-psoriasis",
                        "cleared",
                        "China",
                        "import"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}